Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hindustan Bio SciencesBOM:532041 +2.27%51 Median PS Value is ₹2.66 as of Aug. 03, 2026, which is 100% below its 10-year median of 4.50. GuruFocus rates BOM:532041 with a GF Score™ of 51/100 and a GF Value™ of ₹6.11 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 547 Drug Manufacturers companies, Hindustan Bio Sciences ranks worse than 95.61% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Hindustan Bio Sciences's Median PS Value or its related term are showing as below:
BOM:532041'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 2.57 Med: 4.5 Max: 11.11
Current: 2.71
During the past 13 years, the highest Price to Median PS Value of Hindustan Bio Sciences was 11.11. The lowest was 2.57. And the median was 4.50.
BOM:532041's Price-to-Median-PS-Value is ranked worse than 95.61% of 547
companies
in the Drug Manufacturers industry
Industry Median: 0.87
vs BOM:532041: 2.71
Hindustan Bio Sciences (BOM:532041) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Hindustan Bio Sciences's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
7.20
/
2.66
=
2.71
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hindustan Bio Sciences Median PS Value Related Terms
Hindustan Bio Sciences Median PS Value Historical Data
* Premium members only.
The historical data trend for Hindustan Bio Sciences's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hindustan Bio Sciences Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Hindustan Bio Sciences's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 3.8719.
Hindustan Bio Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.687.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hindustan Bio Sciences (BOM:532041) has a Median PS Value of ₹2.66 as of Aug. 03, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Hindustan Bio Sciences and its competitors. This is 41% below median its historical median of 4.50. Over the past decade, Hindustan Bio Sciences' Median PS Value has ranged from 2.57 to 11.11. According to the industry distribution chart, Hindustan Bio Sciences ranks #523 out of 547 companies in the Drug Manufacturers industry, placing it in the top 95.6%.
Is Hindustan Bio Sciences' Median PS Value too high?
Hindustan Bio Sciences' current Median PS Value of ₹2.66 is 41% below median its 10-year median of 4.50. Over the past 10 years, this metric has ranged from a low of 2.57 to a high of 11.11. Based on the distribution chart, Hindustan Bio Sciences ranks #523 out of 547 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Hindustan Bio Sciences has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hindustan Bio Sciences' Median PS Value compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Hindustan Bio Sciences ranks #523 out of 547 companies for Median PS Value. This places Hindustan Bio Sciences in the lower half of its industry. The industry median Median PS Value is 0.87. Historically, Hindustan Bio Sciences' own Median PS Value has ranged from 2.57 to 11.11 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.87, based on 547 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Hindustan Bio Sciences and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hindustan Bio Sciences's current Median PS Value is ₹2.66, which is 41% below median its own 10-year median of 4.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hindustan Bio Sciences stock overvalued right now?
Based on GuruFocus' analysis, Hindustan Bio Sciences (BOM:532041) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹6.11, compared to a current price of ₹7.20 — trading 17.8% above its estimated fair value. The current Median PS Value is ₹2.66, which is 41% below median its 10-year median of 4.50. Hindustan Bio Sciences' overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Hindustan Bio Sciences (BOM:532041), the current Median PS Value is ₹2.66 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hindustan Bio Sciences (BOM:532041) Overvalued in 2026?
Based on GuruFocus' analysis, Hindustan Bio Sciences stock appears to be overvalued.
The current stock price of ₹7.20 is trading 17.8% above its estimated GF Value™ of ₹6.11.
GuruFocus considers Hindustan Bio Sciences to be Modestly Overvalued.
Key valuation signals for BOM:532041:
Median PS Value: ₹2.66 (41% below median its 10-year median of 4.50)
GF Value™: ₹6.11 vs. price of ₹7.20 (17.8% above fair value)
No single metric tells the full story. See the BOM:532041 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hindustan Bio Sciences Ltd is an Indian pharmaceutical company, engaged in the manufacturing and sale of pharmaceutical products. The company manufactures and markets drugs and medicines in tablets, capsules, drops, externels, and syrup forms. Geographically, all of its revenue is generated through the export of its products to international markets.
51GF Score
Get the complete analysis for BOM:532041
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532041 has been successfully added to your 
